Millions of Medicare-qualifying adults will have access to popular weight loss medications at deep discounts through a temporary federal program called the Medicare GLP-1 Bridge. The program, which starts this summer, will offer pill or injected forms of semaglutide, tirzepatide, and orforglipron for $50 per month.
Eligibility and Benefits
To qualify, individuals must be 18 or older, participate in the Medicare part D drug coverage program, and meet certain health criteria. The program aims to help older adults with obesity, which is a major contributor to various diseases of aging, including heart disease, cancer, dementia, arthritis, and diabetes.
Recent studies have shown that GLP-1 medications, such as semaglutide and tirzepatide, can help adults over 65 lose weight and improve their health outcomes. However, medical experts caution that these medications may have side effects, particularly in older adults, and should be used under the guidance of a healthcare professional.
Experts also emphasize the importance of considering the potential risks and benefits of these medications, particularly for older adults who may have underlying health conditions or be taking other medications. Resistance exercise, such as weightlifting, is also recommended to help maintain muscle mass and prevent falls.
Original reporting: KEYT (Ventura/Santa Barbara) — read the source article.
